Skip to main content
BioNumerik Pharmaceuticals, Inc. Home Page

The BioNumerik Difference

Our Mission

Create and develop innovative new medicines for cancer patients aimed at cure and control of disease, and to prevent serious side effects of cancer treatment.


Our Vision

To discover and develop innovative new cancer treatments by the integration of medicine, pharmaceutical sciences, physics-based molecular simulation and high-performance information technology.

Product Candidates

TAVOCEPT®

We are developing Tavocept as an investigational new drug with potential for oncology and non-oncology indications. read more

KARENITECIN®

We are developing Karenitecin as an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. read more